Edmond Fischer, Biochemist and Nobel Laureate, Dies at 101

Fischer was recognized for his work with reversible protein phosphorylation.

Written byLisa Winter
| 2 min read
Old man wearing glasses looks up and to the left.

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: CHRISTIAN FLEMMING/LINDAU NOBEL LAUREATE MEETINGS

Biochemist Edmond Fischer, who codiscovered the mechanism of reversible phosphorylation alongside Edwin Krebs, died in his adopted hometown of Seattle on August 27 at the age of 101.

Fischer was born in Shanghai, China, in 1920 to a French mother and an Austrian father. According to his autobiography, he began primary school at a local French-language institution but joined his older brothers at a Swiss boarding school at age seven. Throughout high school, he studied piano, and even thought about becoming a musician. But he began studying chemistry in college at the University of Geneva, earning his National License Diploma (a step between a Bachelor’s and a Master’s) in biology and chemistry during World War II.

He stayed on at the university, and in 1947, completed his doctoral thesis on the structure of polysaccharides and of alpha-amylase, an enzyme that breaks them down. He ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies